Clinical Trial

Music Therapy on State Anxiety Levels and Well-being During Chemotherapy

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 29, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
Introduction: Many cancer patients experience high levels of anxiety during chemotherapy, which can negatively impact their mental health and physiological, emotional, and spiritual well-being. Various complementary therapies exist to mitigate these effects, including music therapy. Although preliminary evidence supports the positive effects of music therapy and music-based interventions in chemotherapy, few studies report live group interventions conducted by accredited music therapists. Objective: To determine the effect of a single session of live group music therapy on state anxiety levels and well-being in adult cancer patients undergoing chemotherapy. Methodology: This study is a multicenter, randomized clinical trial with two arms. The intervention group will receive standard care plus a live group music therapy session, while the control group will receive standard care only. The primary outcome measure is the State-Trait Anxiety Inventory (STAI-E), and the secondary outcome measure is well-being, assessed using the Well-being Numerical Rating Scales (WB-NRSs). The scales will be administered before and after each intervention. The sample size is 102 patients. Expected Results: This study aims to improve the psycho-emotional health and well-being of cancer patients during chemotherapy, thereby enhancing the quality of care.
Trial Details
NCT Number NCT06577324
Lead Sponsor Claudia Aristizábal
Collaborators: SONO, keralty, Clinica El Carmen, Clínica Sebastián de Belalcázar
Conditions Anxiety State, Well-Being, Psychological
Enrollment 102 participants
Start Date 2024-09-01
Primary Completion 2025-09-01 (estimated)
Study Completion 2025-09-01 (estimated)
Updated on ClinicalTrials.gov 2024-08-29